Architecture fit
25%Evidence: Braid-only, coil-only, and hybrid process capability map with examples from the same shaft size range.
Scoring: 0 = claimed only; 1 = similar process shown; 2 = same architecture and size family verified.
Manufacturer Selection Tool
Braid and Coil Reinforced Catheter Shaft Manufacturer
Use this braid and coil reinforced catheter shaft manufacturer screen to determine the right type of manufacturing partner: prototype shop, integrated CDMO, or high-volume OEM, based on your shaft complexity, project stage, and critical requirements.
Match supplier profile to project stage.
Focus on process validation and QMS.
Prepare technical RFQ inputs early.
Engineering and regulatory caveat
This manufacturer screen is an RFQ planning aid, not clinical, legal, or regulatory advice. Treat lead-time, tolerance, and validation-cost ranges as 2026 screening assumptions until your drawings, device classification, test methods, supplier capability data, and quality agreement confirm them.
Evidence to Request
Verify the Manufacturer Beyond the Quote
A credible manufacturer should show process evidence that matches the architecture and program phase, not just quote a lead time or unit price.
- In-line laser micrometer or vision inspection records for OD, transition-zone location, and wall-thickness variation.
- Cross-section images that confirm braid/coil placement, encapsulation, concentricity, and jacket bonding.
- A validation plan that explains IQ/OQ/PQ responsibilities, drawing control, sample traceability, and change-control triggers.
- SPC or capability data tied to the same process family as your requested catheter shaft, not an unrelated product line.
RFQ Scorecard
Score Manufacturer Fit Before Supplier Lock
Use this scorecard before comparing price. Rate each category 0, 1, or 2, multiply by the weight, and treat any zero in validation readiness or transition-zone control as a supplier-risk review item.
Transition-zone control
20%Evidence: Inspection plan for braid-to-coil overlap, stiffness transition, reflow bonding, and cross-section review.
Scoring: 0 = no zone method; 1 = manual checks only; 2 = documented in-line or lot-level evidence.
Validation readiness
25%Evidence: Validation responsibility matrix covering IQ/OQ/PQ, sample traceability, drawing control, and change triggers.
Scoring: 0 = no validation plan; 1 = template only; 2 = plan tied to your CTQs and device phase.
Commercial fit
15%Evidence: Quoted sample lead time, MOQ, annual capacity, NRE assumptions, and ramp plan by project phase.
Scoring: 0 = generic quote; 1 = phase-specific quote; 2 = quote includes ramp risks and decision gates.
Quality evidence
15%Evidence: QMS certificate scope, supplier controls, SPC/capability data, inspection records, and release documentation.
Scoring: 0 = certificate only; 1 = selected records; 2 = records align to the proposed process family.
Minimum RFQ pack: controlled drawing, braid/coil zone map, target ID/OD tolerances, expected annual volume, intended tests, material stack, CTQ list, validation scope, and required release documentation.
Key Takeaways for Sourcing
Understand the critical path for successfully transferring a reinforced catheter design to an external manufacturer.
Align manufacturer profile with your program phase
Evidence: A prototype house optimizes for speed (1-3 weeks turnaround) and iterative testing. An OEM optimizes for locked processes and high yield, requiring 8-12+ weeks for setup. Mixing the two causes delays.
Basis / limit: Planning benchmark for RFQ screening; confirm quoted lead time with the selected supplier and project scope.
Action: Use the tool to classify your current stage, and only request quotes from manufacturers capable of supporting that specific phase.
Hybrid shafts demand advanced transition-zone validation
Evidence: The transition between braid and coil reinforcement often causes stiffness jumps, delamination, or OD deviations exceeding ±0.002″.
Basis / limit: Engineering risk model for hybrid shaft transfer; final limits require drawing-level tolerances, test methods, and supplier capability data.
Action: Ask the manufacturer for proof of in-line laser micrometer inspection or cross-sectional microscopy workflows if they are quoting hybrid shafts.
Process validation (IQ/OQ/PQ) is the true cost driver
Evidence: While material costs matter, the labor and time required to validate a new catheter manufacturing line dictate the NRE (Non-Recurring Engineering) cost, which typically ranges from $10,000 to $50,000+ for standard shafts, scaling higher for Class III devices.
Basis / limit: Cost band is an RFQ planning assumption. Regulatory obligations should be checked against QMSR, ISO 13485, the device class, and the validation plan.
Action: Request the manufacturer’s Master Validation Plan (MVP) template before signing a supply agreement to baseline expected NRE.
Quality systems are non-negotiable for scale
Evidence: With the FDA transition to QMSR (incorporating ISO 13485), supplier controls and design transfer records are strictly audited. Poor concentricity or erratic wire tension must be caught by automated systems.
Basis / limit: Source-backed by FDA QMSR and ISO 13485 quality-system requirements; inspection technology depends on supplier equipment.
Action: Evaluate the manufacturer’s DHF (Design History File) transfer process early in the RFQ phase to prevent costly requalification cycles.
Supplier Selection and Handoff Flow
Determine Program Phase
Acknowledge whether you need fast iterative samples (1-3 weeks) or locked validation lots with full IQ/OQ/PQ data.
Define Critical Architecture
Identify if the shaft is braid-only, coil-only, or a complex hybrid. Clearly define transition zone tolerances (e.g., ±1mm overlap).
Prepare RFQ Package
Assemble drawings (with ±0.001″ to ±0.002″ standard OD tolerances), target volumes, testing requirements, and quality clauses.
Audit and Select
Review the manufacturer’s capabilities, especially around in-line laser inspection and process validation history.
Ready to Request a Quote?
Ensure you have your architecture defined, target volumes set, and a clear understanding of your quality validation requirements before engaging.
Comparing Manufacturer Profiles
The type of manufacturer you select drastically changes lead times, costs, and flexibility. Evaluate the tradeoffs carefully.
R&D
Prototype House
Optimized for fast iterative loops and small sample batches. Ideal for early feasibility testing.
V&V
Integrated CDMO
Balances design flexibility with strict quality systems necessary for process validation and clinical builds.
Scale
OEM
High-Volume OEM
Rigid processes designed for lowest unit cost and maximum yield at commercial scale.
Ideal Project Stage
- Prototype House
- Concept, feasibility, material DOE
- Integrated CDMO
- Design freeze, V&V, clinical builds
- High-Volume OEM
- Commercial launch, high-volume scaling
Speed to first sample
- Prototype House
- 1-3 weeks (rapid)
- Integrated CDMO
- 4-8 weeks (controlled)
- High-Volume OEM
- 8-12+ weeks (highly rigid)
OD Tolerance Capability
- Prototype House
- ±0.002″ to ±0.003″ (manual checks)
- Integrated CDMO
- ±0.001″ to ±0.002″ (in-line laser micrometer)
- High-Volume OEM
- Down to ±0.0005″ (automated vision & closed-loop)
Validation NRE Cost
- Prototype House
- Low to None (R&D builds)
- Integrated CDMO
- $15k - $50k+ (IQ/OQ/PQ execution)
- High-Volume OEM
- Highest (Dedicated automated line setup)
Design changes
- Prototype House
- Expected and encouraged
- Integrated CDMO
- Managed via strict change control
- High-Volume OEM
- Highly resistant, requires requalification
Comparison ranges are used for early supplier screening only. Final lead times, OD tolerance, NRE, and validation evidence must be confirmed in the RFQ, drawing review, quality agreement, and supplier capability study.
Supplier Risks and Mitigation
Premature scale-up with an OEM
High impactTrigger: Moving to a high-volume manufacturer before the design is frozen, leading to massive requalification costs for minor tweaks.
Mitigation: Use an R&D house or flexible CDMO until clinical trials and V&V are completed.
Validation data gaps
High impactTrigger: Prototype supplier lacks ISO 13485 controls to generate compliant IQ/OQ/PQ records, forcing a complete restart of validation.
Mitigation: Audit the supplier QMS early. Plan for a formal design transfer if moving from a prototype shop to a commercial CDMO/OEM.
Transition zone failures (Hybrid shafts)
Medium impactTrigger: Manufacturer lacks automated inspection for the precise point where braid meets coil, leading to kinking or delamination.
Mitigation: Specify transition overlap tolerances (e.g., ±1mm) on drawings and mandate vision inspection or cross-sectioning in the control plan.
Poor Concentricity (Wall Thickness Variation)
High impactTrigger: Inconsistent extrusion or braiding tension creates "thin spots," leading to shaft bursting under clinical pressures.
Mitigation: Mandate strict ID/OD tolerances (e.g., ±0.001″) and require statistical process control (SPC) data for continuous extrusion runs.
Quality & Regulatory References
These standards drive the process documentation requirements you should expect from a competent manufacturer.
Date / status
Effective February 2, 2026; reviewed July 30, 2026
Use on this page
Frames the current FDA quality-system baseline for transferring catheter shaft designs to a contract manufacturer.
Date / status
2016 edition; referenced by the FDA QMSR transition
Use on this page
Defines the medical-device quality management system controls that supplier selection and design transfer should account for.
Date / status
Published November 2023
Use on this page
Provides the testing baseline for intravascular catheters, which a manufacturer must be able to validate against.
Date / status
Current federal regulation text; use with QMSR/ISO 13485 context
Use on this page
Provides the current legal text for FDA medical-device quality system requirements. IQ/OQ/PQ remains a validation-planning convention, not a standalone Part 820 guideline.
Manufacturer Selection FAQ
Related Topics
Braid and Coil Reinforced CDMO GuideReview architectural screening for CDMO sourcing.OEM CapabilitiesSee how integrated manufacturers control scale and quality.Contract Manufacturing StrategyDeep dive into supplier selection for long-term production.Catheter Shaft Cost DriversUnderstand what impacts unit price and NRE during manufacturing.DFM ChecklistConvert supplier feedback into manufacturable drawings and CTQs.Inspection GuideReview inspection methods for OD, concentricity, and transition zones.
Send a Manufacturer RFQ Package
Share drawings, zone maps, expected annual volume, tolerance stack-up, target tests, and validation expectations so the manufacturer discussion starts with the right evidence.